This tax notice arrives as Epigral navigates robust fundamentals, including reduced net debt/EBITDA to 0.6x and focus on import substitution. While the demand equals a notable portion of quarterly PAT, Epigral's solid balance sheet offers resilience. No immediate disclosure on appeal plans, but firms typically contest such notices. Monitor BSE/NSE filings for updates.
Epigral Ltd, a leading Indian chemical manufacturer, has received a hefty tax demand order of Rs 525.2 million from authorities. This development, reported on January 1, 2026, could pressure the company's finances amid its ongoing growth trajectory. Investors await the firm's response and potential appeal.
Key Highlights
Tax Demand Amount: Rs 525.2 million (Rs 52.52 crore), issued recently as per market updates.
Company Profile: Epigral specializes in integrated chemicals like CPVC and Epichlorohydrin, with strong Q1 FY26 revenue of Rs 615 crore and EBITDA margins at 27%.
Recent Performance: Q1 FY26 PAT stood at Rs 160 crore (adjusted Rs 79 crore ex-deferred tax), plant utilization at 73%, ROCE up to 24%.
Strategic Outlook: Expansion in derivatives/specialty segments (50% revenue share), capex on capacity enhancements on track for H2 FY26 commissioning.
Market Reaction: Shares may face volatility; company likely to challenge the order via appeal, a common step in such cases.
Sources: TradingView (Refinitiv), MarketScreener, Indian Chemical News